HeartBeam, Inc. (BEAT): Price-to-Projected Revenue Ratio

heartbeam.com - graphic logo of issuer BEAT

HeartBeam, Inc. (BEAT) aims for global cardiac market dominance by scaling its B2B 3D diagnostics services. The business's forward P/S ratio clearly demonstrates the company's market valuation, where the metric determines this level. The development of portable monitors in the US relies on growing demand for remote monitoring. However, negative cash flow and the anticipation of regulatory approvals leave the business dependent on external investment.

BEAT (heartbeam.com) Forward Price to Sales history from 07/04/2022 to 11/13/2026

HeartBeam Corporation - analytical breakdowns and key metrics (BEAT)

- current price and projected stock value:
Stock Price HeartBeam|BEAT - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value HeartBeam Corporation|BEAT - Real Price to Acquire Entire Company
- book value of equity indicators:
Accounting Value per Share HeartBeam|BEAT - Accounting Value of Company|Market Capitalization to Book Value Ratio heartbeam.com|BEAT - Company Total Asset Base
- debt level and financial liquidity data:
Debt to Equity HeartBeam, Inc.|BEAT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital HeartBeam, Inc.|BEAT - Company Total Debt|Debt to Book Value HeartBeam Corporation|BEAT - Long-Term Debt Volume|Company Short-Term Debts HeartBeam|Quick Ratio heartbeam.com
- net income and valuation multiples indicators:
BEAT - Company Net Income|Projected Future Earnings HeartBeam, Inc.|BEAT - P/E Multiple|Projected Price to Earnings HeartBeam Corp|BEAT - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple HeartBeam Corporation|BEAT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) HeartBeam|BEAT - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth heartbeam.com|BEAT - Earnings growth in current year|Net earnings per share growth forecast for next year HeartBeam, Inc.
- company sales and revenue statistics:
BEAT - Company Sales Revenue|Company Future Sales Volume HeartBeam|BEAT - Market Cap to Sales Volume|Forward P/S Multiple HeartBeam Corporation
Analysis of all company metrics:HeartBeam (BEAT)
Original product of HeartBeam Corporation

HeartBeam, Inc. (BEAT) expansion into the portable AI ECG monitoring segment provides a foundation for revenue scaling, which is reflected in the dynamics of the expected revenue multiple. This indicator compares current market capitalization with projected sales volume, allowing investors to assess the extent of market expectations currently priced in and determine the boundaries of the business's fair value during its commercial growth phase.

Analysis of competing companies

Forward P/S Multiple REGN (Regeneron)|Forward P/S Multiple iRhythm Technologies, Inc. IRTC|LNTH - Price-to-Projected Revenue Ratio|Mineralys Corp (MLYS) - Forward Price-to-Revenue Multiple|HTFL (heartflow.com) - Forward Price-to-Revenue Multiple|kestramedical.com - Forward Price to Sales|ESPR (Esperion) - Forward P/S Multiple|Amarin Corporation (AMRN) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Anteris Technologies Global (AVR)|tenayatherapeutics.com - Market Cap to Projected Revenue|Forward P/S Multiple CVRX (CVRx, Inc.)|MIST - Forward Price-to-Revenue Multiple|CRDL: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Tenax Therapeutics Inc. TENX|ADGM: Forward P/S Multiple|BCDA (BioCardia Inc) - Price-to-Projected Revenue Ratio|VTAK (Catheter Precision) - Forward P/S Multiple|Market Cap to Future Revenue Ratio ARCA Bio ABIO|Forward P/S Multiple ACST|Forward P/S Multiple Aerovate Therapeutics Inc. (AVTE)|Verve Therapeutics, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio WINT (Windtree Therapeutics Inc.)